MedBud has been incorporated as a non-profit organisation, with Dr. Tahzid Ahsan (Specialist Psychiatrist) joining as medical director Announcement on X/Twitter

Back to Tilray® or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Comparative Values)

Alpha-Pinene2.91%Pine/Sharp156℃
Beta-Pinene2.91%Pine/Herbal165℃
Myrcene8.12%Herbal/Musk166-168℃
Limonene14.14%Citrus/Sour177℃
Caryophyllene31.8%Pepper/Spice119℃
Linalool7.07%Floral/Spice198℃
Humulene12.72%Woody/Earthy107℃
Eucalyptol0.9%Mint/Camphor167-168℃
Nerolidol19.43%Woody/Floral122℃

MedBud currently tracks 16 common terpenes, more will be added.

Dosing Look-Up Table (Estimated)

0.01/g0.9/mg THC0.9/mg CBD
0.05/g4.5/mg THC4.5/mg CBD
0.1/g9/mg THC9/mg CBD
0.15/g13.5/mg THC13.5/mg CBD
0.2/g18/mg THC18/mg CBD
0.25/g22.5/mg THC22.5/mg CBD
0.3/g27/mg THC27/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
America Tilray®
Designation
T9:C9
Cultivar/Strain
Warlock
Classification
Indica Hybrid
Chemotype
Type II: THC/CBD Mix
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
8.1-9.9%
CBD Potential Range (±10%)
9%
Cultivated/Produced by
Portugal Tilray Medical
Cultivated or Packaged in
Flag of Portugal Portugal
Irradiation
Gamma-Irradiated
Imported by
United Kingdom IPS Pharma
Imported as
Schedule II: Finished Product

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Mid March

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

About Warlock

WrlIndica Hybrid

Warlock expresses some Sativa traits not only in terms of growth but also the effects it can produce. The high starts off cerebral but then tapers off into a relaxing body buzz.

Serious Seeds Logo

Bred by Dutch Flag Serious Seeds

Created entirely by accident, the magic of the mostly-Indica Warlock comes from Magus Genetics. In the early 1990s the founder of Magus Genetics, Gerrit Slot began an outdoor grow with some landrace Afghanistan Indica seeds and Skunk #1 seeds. While growing the male Afghani plants pollinated a Skunk #1 female, creating a ton of F1 hybrid seeds. The following year Gerrit moved to an indoor setup and grew some clone that he got from a friend, as well as the Skunk #1 and the accidental hybrid seeds. As the plants grew he took notice of the fact that the hybrids were doing better than the pure Skunk plants but they lacked the flavor and aroma of the Skunk. Having run out of the pure Skunk seeds, Gerrit decided to cross the last of his female Skunks with pollen from some of the male hybrids. The children from this coupling grew as strongly as the F1 hybrids and had an even better smell and taste than the original Skunk plants. Warlock is the final result that would go on to be the mainstay of Magus Genetics, which would be used in nearly all their later strains.

Even though the strain is Indica dominant, Warlock expresses some Sativa traits not only in terms of growth but also the effects it can produce. The high starts off cerebral but then tapers off into a relaxing body buzz. It may be used to alleviate chronic aches and pains, migraines, anxiety, stress, fatigue, nausea and depression.

Warlock is a strain that can be grown well in any medium, thriving inside and outdoors in locations with warmer a autumn. It should be left in the vegetative cycle for about 35 days before forcing the flowering period, which lasts between eight and nine weeks. When grown outside, plants are ready for harvest at the end of October or early November. Since this strain will take up all the space given to it, plants will need to be well manicured to ensure maximum bud growth. Fortunately, Warlock has a high calyx-to leaf ratio.

Description provided by Wikileaf.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

America About Tilray Inc.

Tilray® Logo

A global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.

Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.

A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.

Tilray's experience is unmatched worldwide. Our team of professionals on the ground in 7 countries serves tens of thousands of patients and consumers around the globe. Our GMP-certified cultivation and production facilities are among the most advanced in the world.

We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.

Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.

tilray.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)